Cytomegalovirus (CMV) is particularly dangerous in systemic lupus erythematosus (SLE), being a problem both for the differential diagnosis with disease flare and for the management of SLE flare with immunosuppressive drugs. We report on four cases of SLE with concomitant CMV infection, having some common clinical and laboratory characteristics. Our data suggest that lupus patients presenting with symptoms such as fever, diarrhea, and respiratory symptoms, alone or in combination, and laboratory evidence of leukopenia, elevated transaminases, and hyponatremia, especially in the setting of recent immunosuppressive treatments, should be screened for CMV.
CerveraRKhamashtaMAFontJSebastianiGDGilALavillaPet al.European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore)2003; 82: 299–308.
2.
GoldblattFChambersSRahmanAIsenbergDA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus2009; 18: 682–689.
3.
Navarro-ZarzaJEAlvarez-HernándezECasasola-VargasJCEstrada-CastroEBurgos-VargasR. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus2010; 19: 43–48.
Ruiz-IrastorzaGOlivaresNRuiz-ArruzaIMartinez-BerriotxoaAEgurbideMVAguirreC. Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther2009; 11: R109–R109.
6.
SebastianiGDIulianoAPreveteIMinisolaG. Opportunistic infections in systemic lupus erythematosus. Int J Clin Rheumatol2012; 7: 275–279.
7.
HoussiauFAVasconcelosCD’CruzDSebastianiGDde Ramon GarridoEDanieliMG. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum2002; 46: 2121–2131.
8.
Ramos-CasalsMCuadradoMJAlbaPSannaGBrito-ZeronPBertolacciniL. Acute viral infections in patients with systemic lupus erythematosus. Description of 23 cases and review of the literature. Medicine2008; 87: 311–318.
9.
ValadkhaniBKargarMAshouriAHadjibabaieMGholamiKGhavamzadehA. The risk factors for cytomegalovirus reactivation following stem cell transplantation. J Res Pharm Pract2016; 5: 63–69.
10.
Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. http://aidsinfo.nih. gov/guidelines (accessed 19 September 2016).
11.
KottonCNKumarDCaliendoAMAsbergAChouSDanziger-IsakovLet al.Updated international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation2013; 96: 333–360.
12.
TsaiWPChenMHLeeMHYuKHWuMWLiouLB. Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan. Rheumatol Int2012; 32: 2901–2908.
13.
LeeKYYooB-WAhnSSBaeWHLeeHJungSMet al.Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR. PLoS ONE2017; 12(7): e0181590–e0181590.
14.
MoscaMTaniCAringerMBombardieriSBoumpasDBreyRet al.European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis2010; 69: 1269–1274.
15.
LiuPTanHZLiHLimCCChooJCJ. Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes. Lupus2018; 27: 1150–1158.
16.
SciasciaSCuadradoMJKarimMY. Management of infection in systemic lupus erythematosus. Best Pract Res Clin Rheumatol2013; 27: 377–389.
17.
CamaraISciasciaSSimoesJPazzolaGSalasVKarimYet al.Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre. Clin Exp Rheumatol2014; 32: 41–47.
18.
KamaliSCefleASayarliogluMGulAInancMOcalLet al.Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatol Int2005; 25: 211–214.
